| Louise Marie Mcnamara, APRN | |
|
615 1st Ave Ne, Suite 310, Minneapolis, MN 55413-2447 | |
| (612) 436-0295 | |
| (612) 436-0163 |
| Full Name | Louise Marie Mcnamara |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 45 Years |
| Location | 615 1st Ave Ne, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104947241 | NPI | - | NPPES |
| 575G4MC | Other | MN | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | R 117501-5 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mental Health Counseling Services Llc | 3173675790 | 19 |
News Archive
XenoPort, Inc. announced today that it had reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for a pivotal Phase 3 clinical trial of arbaclofen placarbil, previously known as XP19986, as a potential treatment of spasticity in multiple sclerosis patients.
UIC College of Nursing associate professor Susan Dunn explores this question as lead author of "Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness," a paper published in the January/February edition of Nursing Research.
Kite, a Gilead Company, and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors, have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.
The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant deviations from current good tissue practice and current good manufacturing practice requirements, including some violations that may have led to microbial contamination, potentially causing serious blood infections in patients.
JDSU is advancing the world of polarization optics with today's announcement of its ability to combine thin-film and liquid crystal polymer technologies to produce high-quality custom birefringent components.
› Verified 3 days ago
| Entity Name | Mental Health Counseling Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679717524 PECOS PAC ID: 3173675790 Enrollment ID: O20090713000471 |
News Archive
XenoPort, Inc. announced today that it had reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for a pivotal Phase 3 clinical trial of arbaclofen placarbil, previously known as XP19986, as a potential treatment of spasticity in multiple sclerosis patients.
UIC College of Nursing associate professor Susan Dunn explores this question as lead author of "Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness," a paper published in the January/February edition of Nursing Research.
Kite, a Gilead Company, and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors, have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.
The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant deviations from current good tissue practice and current good manufacturing practice requirements, including some violations that may have led to microbial contamination, potentially causing serious blood infections in patients.
JDSU is advancing the world of polarization optics with today's announcement of its ability to combine thin-film and liquid crystal polymer technologies to produce high-quality custom birefringent components.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louise Marie Mcnamara, APRN 615 1st Ave Ne, Suite 310, Minneapolis, MN 55413-2447 Ph: (612) 436-0295 | Louise Marie Mcnamara, APRN 615 1st Ave Ne, Suite 310, Minneapolis, MN 55413-2447 Ph: (612) 436-0295 |
News Archive
XenoPort, Inc. announced today that it had reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for a pivotal Phase 3 clinical trial of arbaclofen placarbil, previously known as XP19986, as a potential treatment of spasticity in multiple sclerosis patients.
UIC College of Nursing associate professor Susan Dunn explores this question as lead author of "Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness," a paper published in the January/February edition of Nursing Research.
Kite, a Gilead Company, and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors, have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.
The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant deviations from current good tissue practice and current good manufacturing practice requirements, including some violations that may have led to microbial contamination, potentially causing serious blood infections in patients.
JDSU is advancing the world of polarization optics with today's announcement of its ability to combine thin-film and liquid crystal polymer technologies to produce high-quality custom birefringent components.
› Verified 3 days ago
Janet Mae Swanson, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave South, Hennepin County Medical Center/revenue Management, Minneapolis, MN 55415 Phone: 612-873-3044 Fax: 612-630-8242 | |
Ms. Natalie Ann Rosen, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2545 Chicago Ave, Minneapolis, MN 55404 Phone: 612-863-1940 Fax: 612-863-2596 | |
Kathryn Ann Fiebelkorn Westman, APRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 122-627-8006 Fax: 612-262-7022 | |
Sue Towey, RN,CNS,MS,LP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1409 Willow St, Suite 100, Minneapolis, MN 55403 Phone: 612-377-0898 Fax: 612-377-1101 | |
Ms. Judy A. Wilking, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2001 Bloomington Ave, Minneapolis, MN 55404 Phone: 612-638-0700 | |
Noela Kleinman, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 333 Washington Ave N, Suite 5000, Minneapolis, MN 55401 Phone: 612-659-7111 Fax: 612-659-7101 | |
Pauline Ann Johnson, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-4238 Fax: 612-727-5693 |